Berlin, Germany

Olaf Prien

USPTO Granted Patents = 14 

Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Profile: Olaf Prien

Introduction

Olaf Prien is a notable inventor based in Berlin, Germany, with a remarkable portfolio of 14 patents. His innovative contributions primarily revolve around pharmaceutical compounds, showcasing his expertise in medicinal chemistry and drug development.

Latest Patents

One of Olaf Prien's latest patents is for substituted triazolopyridines. This invention relates to compounds of a specific general formula designed to target diseases characterized by uncontrolled cell growth, proliferation, and survival. It outlines methods for the preparation of these compounds, along with their pharmaceutical compositions and combinations for effective therapeutic use.

Another significant invention by Prien is focused on oxo-substituted imidazo[1,2-B]pyridazines. This patent introduces novel inhibitors of kinases, detailing their preparation methods and potential applications in the pharmaceutical industry. These inhibitors are critical for advancing treatments targeting various diseases.

Career Highlights

Throughout his career, Olaf Prien has worked with prestigious organizations such as Bayer Schering Pharma AG and Schering Aktiengesellschaft, where he contributed his knowledge and expertise to innovative projects in the pharmaceutical sector. His work has significantly influenced drug development practices and medical advancements.

Collaborations

During his professional journey, Prien has collaborated with esteemed colleagues including Ulrich Lücking and Gerhard Siemeister. These collaborations have enabled him to expand his research capabilities and drive forward the development of groundbreaking pharmaceutical solutions.

Conclusion

Olaf Prien's contributions to patenting and innovation in pharmaceuticals highlight his role as a leading inventor in his field. With a focus on developing key compounds for treating critical health issues, his work continues to impact the landscape of medical research and development significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…